Package 70518-4343-0

Brand: bupropion hydrochloride

Generic: bupropion hydrochloride
NDC Package

Package Facts

Identity

Package NDC 70518-4343-0
Digits Only 7051843430
Product NDC 70518-4343
Product ID 70518-4343_3d84aca4-4ce7-7ecc-e063-6394a90a0360
Description

30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (70518-4343-0)

Marketing

Marketing Status
Marketed Since 2025-05-19
Brand bupropion hydrochloride
Generic bupropion hydrochloride
Sample Package No

Linked Drug Pages (1)

bupropion hydrochloride ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "3d84aca4-4ce7-7ecc-e063-6394a90a0360", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993557"], "spl_set_id": ["d087222e-c5e9-4c48-b27f-e2e2944379c8"], "manufacturer_name": ["REMEDYREPACK INC."]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (70518-4343-0)", "package_ndc": "70518-4343-0", "marketing_start_date": "20250519"}], "brand_name": "bupropion hydrochloride", "product_id": "70518-4343_3d84aca4-4ce7-7ecc-e063-6394a90a0360", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "70518-4343", "generic_name": "bupropion hydrochloride", "labeler_name": "REMEDYREPACK INC.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "bupropion hydrochloride", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "300 mg/1"}], "application_number": "ANDA211020", "marketing_category": "ANDA", "marketing_start_date": "20250519", "listing_expiration_date": "20261231"}